Beijing Health Guard Biotechnology (BJSE:920575) PB Ratio: (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920575 Beijing Health Guard Biotechnology Inc BJSE:920575
47 GF Score
Price ¥5.59
GF Value ¥7.92
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Beijing Health Guard Biotechnology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-27), Beijing Health Guard Biotechnology's share price is ¥5.59. Beijing Health Guard Biotechnology's Book Value per Share for the quarter that ended in Jun. 2026 was ¥-0.43. Hence, Beijing Health Guard Biotechnology's PB Ratio of today is .

The historical rank and industry rank for Beijing Health Guard Biotechnology's PB Ratio or its related term are showing as below:

During the past 13 years, Beijing Health Guard Biotechnology's highest PB Ratio was 14.44. The lowest was 3.37. And the median was 7.54.

BJSE:920575's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.95
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Beijing Health Guard Biotechnology's average Book Value Per Share Growth Rate was -130.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Beijing Health Guard Biotechnology was 251.20% per year. The lowest was -40.20% per year. And the median was 15.10% per year.

Back to Basics: PB Ratio


Beijing Health Guard Biotechnology  (BJSE:920575) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Beijing Health Guard Biotechnology PB Ratio Related Terms


Beijing Health Guard Biotechnology PB Ratio Historical Data

* Premium members only.

The historical data trend for Beijing Health Guard Biotechnology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Health Guard Biotechnology PB Ratio Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 8.41 8.40 0.00

Beijing Health Guard Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.97 14.44 0.00 0.00 0.00

BJSE:920575 vs VRTX, REGN, RVMD: PB Ratio Comparison

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Health Guard Biotechnology PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's PB Ratio falls into.


BJSE:920575
47GF Score
Beijing Health Guard Biotechnology Inc BJSE:920575
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Health Guard Biotechnology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Beijing Health Guard Biotechnology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2026)
=5.59/-0.434
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued. The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92. GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.

Key valuation signals for BJSE:920575:

  • PB Ratio:
  • GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
  • GF Score™: 47/100 with 10 warning signs

No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Health Guard Biotechnology Business Description

Address No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score

Get the complete analysis for BJSE:920575

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.59
Price
¥7.92
GF Value